Athletigen Company
Delivering world-class DNA analysis techology to optimize performance in elite athletes and develop precision products
Headquarters:
Canada
Funding Status:
Seed
Investors Number:
3
Founded Date:
2014-03-01
Investor Type:
For Profit
Last Funding Type:
Seed
Employee Number:
11-50
Total Funding:
$1.6M
Industry:
P4 Medicine
Estimated Revenue:
$1M to $10M
Technology:
P4 Medicine
Acquisitions Number:
1